tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Moleculin Biotech Stockholders Approve Share Issuance
Company AnnouncementsMoleculin Biotech Stockholders Approve Share Issuance
2d ago
8K
MBRX
Moleculin Biotech Secures Canadian Patent for Annamycin
PremiumCompany Announcements
Moleculin Biotech Secures Canadian Patent for Annamycin
23d ago
8K
MBRX
Moleculin Biotech announces issuance of Canadian patent covering Annamycin
PremiumThe Fly
Moleculin Biotech announces issuance of Canadian patent covering Annamycin
23d ago
MBRX
Moleculin Biotech files to sell 64.86M shares of common stock for holders
PremiumThe Fly
Moleculin Biotech files to sell 64.86M shares of common stock for holders
29d ago
MBRX
Moleculin Biotech’s Strategic Expansion and Promising Data Support Buy Rating
PremiumRatings
Moleculin Biotech’s Strategic Expansion and Promising Data Support Buy Rating
1M ago
MBRX
Moleculin Biotech Expands Global Phase 2B/3 Trial
PremiumCompany AnnouncementsMoleculin Biotech Expands Global Phase 2B/3 Trial
1M ago
8K
MBRX
Moleculin Biotech accelerates recruitment in Phase 3 MIRACLE trial
Premium
The Fly
Moleculin Biotech accelerates recruitment in Phase 3 MIRACLE trial
1M ago
MBRX
Moleculin Biotech Releases New Corporate Presentation
Premium
Company Announcements
Moleculin Biotech Releases New Corporate Presentation
1M ago
8K
MBRX
Moleculin Biotech Begins Phase 2B/3 MIRACLE Trial Enrollment
PremiumCompany Announcements
Moleculin Biotech Begins Phase 2B/3 MIRACLE Trial Enrollment
1M ago
8K
MBRX
Moleculin Biotech doses first EU patient in Phase 3 MIRACLE trial
PremiumThe Fly
Moleculin Biotech doses first EU patient in Phase 3 MIRACLE trial
1M ago
MBRX
Promising Annamycin Trials Boost Moleculin Biotech’s Outlook Amidst Share Volatility
PremiumRatings
Promising Annamycin Trials Boost Moleculin Biotech’s Outlook Amidst Share Volatility
1M ago
MBRX
Moleculin Biotech Secures $6 Million Through Warrant Agreement
PremiumCompany Announcements
Moleculin Biotech Secures $6 Million Through Warrant Agreement
2M ago
8K
MBRX
Moleculin Biotech announces exercise of warrants for $6M gross proceeds
PremiumThe FlyMoleculin Biotech announces exercise of warrants for $6M gross proceeds
2M ago
MBRX
Optimistic Buy Rating for Moleculin Biotech Based on Promising Annamycin Data and Future Potential
Premium
Ratings
Optimistic Buy Rating for Moleculin Biotech Based on Promising Annamycin Data and Future Potential
2M ago
MBRX
Moleculin Biotech Completes Promising Annamycin Trial
Premium
Company Announcements
Moleculin Biotech Completes Promising Annamycin Trial
2M ago
8K
MBRX
Moleculin Biotech announces OS data from Phase 1B/2 clinical trial in AML
PremiumThe Fly
Moleculin Biotech announces OS data from Phase 1B/2 clinical trial in AML
2M ago
MBRX
Moleculin Biotech Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Moleculin Biotech Holds 2025 Annual Stockholders Meeting
2M ago
8K
MBRX
Moleculin Biotech Releases New Corporate Presentation
PremiumCompany Announcements
Moleculin Biotech Releases New Corporate Presentation
2M ago
8K
MBRX
Promising Outlook for Moleculin Biotech Amidst Phase 3 Trial Progress and Strong Financial Position
PremiumRatings
Promising Outlook for Moleculin Biotech Amidst Phase 3 Trial Progress and Strong Financial Position
2M ago
MBRX
Moleculin Biotech Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsMoleculin Biotech Reports Q2 2025 Financial Results
2M ago
MBRX
Moleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year
Premium
The Fly
Moleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year
2M ago
MBRX
Moleculin Biotech sees cash runway into Q4
Premium
The Fly
Moleculin Biotech sees cash runway into Q4
2M ago
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >